ISCO 8-K 2026-07-16

International Stem Cell CORP (ISCO) 8-K dated 2026-07-16 — accession 0001683168-26-005555. This URL is the filing, not the ISCO hub.

International Stem Cell CORP (ISCO) is a biotechnology company listed on US.

International Stem Cell CORP filed a 8-K on 2026-07-16. Accession 0001683168-26-005555.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ISCO revenue for 2025-12-31 was $9.1M. Net income was -$418.0K. Revenue was up 0.2% from 2024-12-31 to 2025-12-31. ISCO currently screens at market cap $880.5K.

Not investment advice. The ISCO SEC hub lists recent forms. The stock page is the research view.